Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

PURPOSE: To update eligibility and outcome measures in trials that evaluate systemic treatment for patients with progressive prostate cancer and castrate levels of testosterone. METHODS: A committee of investigators experienced in conducting trials for prostate cancer defined new consensus criteria...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Scher, Howard I., Halabi, Susan, Tannock, Ian, Morris, Michael, Sternberg, Cora N., Carducci, Michael A., Eisenberger, Mario A., Higano, Celestia, Bubley, Glenn J., Dreicer, Robert, Petrylak, Daniel, Kantoff, Philip, Basch, Ethan, Kelly, William Kevin, Figg, William D., Small, Eric J., Beer, Tomasz M., Wilding, George, Martin, Alison, Hussain, Maha
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4010133/
https://ncbi.nlm.nih.gov/pubmed/18309951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.12.4487
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky